ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INFI Infinity Pharmaceuticals Inc

0.0322
0.00 (0.00%)
Last Updated: 20:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.0321
Ask Price 0.0348
News -
Day High

Low
0.0233

52 Week Range

High
0.2597

Day Low
Company Name Stock Ticker Symbol Market Type
Infinity Pharmaceuticals Inc INFI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0322 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.0322
Trades Volume Avg Volume 52 Week Range
0 0 - 0.0233 - 0.2597
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0322 USD

Infinity Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 89.41M - 2.59M -44.37M -0.50 0.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Infinity Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No INFI Message Board. Create One! See More Posts on INFI Message Board See More Message Board Posts

Historical INFI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.19350.25970.02330.127962,398,012-0.1613-83.36%
3 Years3.333.890.02331.751,936,081-3.30-99.03%
5 Years1.925.980.02332.041,410,116-1.89-98.32%

Infinity Pharmaceuticals Description

Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development.

Your Recent History

Delayed Upgrade Clock